Vera therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Brisbane, calif., aug. 09, 2024 (globe newswire) -- vera therapeutics, inc. (nasdaq: vera) today announced that on august 6, 2024, the compensation committee granted inducement awards consisting of a non-qualified stock option to purchase 33,000 shares of class a common stock and restricted stock units (rsus) for 16,500 shares of class a common stock to three new employees under the inducement plan. the compensation committee approved the awards as an inducement material to the new employees' employment in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking